Two Sigma Advisers’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-90,100
| Closed | -$11.5M | – | 2780 |
|
|
2020
Q4 | $11.5M | Sell |
90,100
-57,300
| -39% | -$7.33M | 0.03% | 521 |
|
|
2020
Q3 | $16.6M | Buy |
147,400
+23,700
| +19% | +$2.67M | 0.05% | 366 |
|
|
2020
Q2 | $11.8M | Buy |
123,700
+76,700
| +163% | +$7.31M | 0.03% | 495 |
|
|
2020
Q1 | $4.22M | Buy |
47,000
+38,700
| +466% | +$3.48M | 0.02% | 772 |
|
|
2019
Q4 | $440K | Sell |
8,300
-41,600
| -83% | -$2.21M | ﹤0.01% | 1921 |
|
|
2019
Q3 | $1.97M | Sell |
49,900
-17,400
| -26% | -$688K | ﹤0.01% | 1117 |
|
|
2019
Q2 | $2.77M | Sell |
67,300
-3,000
| -4% | -$123K | 0.01% | 1070 |
|
|
2019
Q1 | $3.27M | Buy |
+70,300
| New | +$3.27M | 0.01% | 996 |
|